LMR Partners’s Centessa Pharmaceuticals CNTA Stock Holding History

LMR Partners’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-125,000	Closed	-$4.96M	–	1550
2026 Q1	$4.96M	Buy	+125,000	New	+$3.2M	0.01%	641

LMR Partners's CNTA Position: Q2 2026 in Review

LMR Partners sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 125,000 shares — an estimated $4.96M sold.

LMR Partners first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $4.96M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

LMR Partners reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
LMR Partners sold 125,000 Centessa Pharmaceuticals shares in Q2 2026, an estimated $4.96M.
LMR Partners first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
LMR Partners's Centessa Pharmaceuticals position peaked at $4.96M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.